Net profit of Nath Bio-Genes (India) rose 147.75% to Rs 2.75 crore in the quarter ended September 2025 as against Rs 1.11 crore during the previous quarter ended September 2024. Sales rose 36.22% to Rs 43.85 crore in the quarter ended September 2025 as against Rs 32.19 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales43.8532.19 36 OPM %13.9114.94 - PBDT4.381.91 129 PBT3.391.09 211 NP2.751.11 148 Powered by Capital Market - Live News

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Net profit of Nath Bio-Genes (India) rose 11.78% to Rs 37.28 crore in the quarter ended June 2025 as against Rs 33.35 crore during the previous quarter ended June 2024. Sales rose 16.33% to Rs 283.70 crore in the quarter ended June 2025 as against Rs 243.88 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales283.70243.88 16 OPM %13.4914.98 - PBDT36.8634.43 7 PBT35.8833.60 7 NP37.2833.35 12 Powered by Capital Market - Live News

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 11 July 2025.Powered by Capital Market - Live News

Nath Bio-Genes (India) announced that the 32nd Annual General Meeting (AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live News